Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon Mangues

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Nanomedicine (London, England)|May 26, 2016
Functional recruitment for drug delivery through protein-based nanotechnologiesEsther Vazquez, Ramon Mangues, Antonio Villaverde
Medical Sciences (Basel, Switzerland)|October 31, 2017
Targeting in Cancer TherapiesRamon Mangues, Esther Vázquez, Antonio Villaverde
Biomarker Research|April 30, 2025
Targeting the chemokine receptor CXCR4 for cancer therapiesAriana Rueda, Naroa Serna, Ramon Mangues, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 28, 2002
Heterotopic implantation alters the regulation of apoptosis and the cell cycle and generates a new metastatic site in a human pancreatic tumor xenograft modelLourdes Farré, Isolda Casanova, Silvia Guerrero, et al.
Microbial Cell Factories|February 11, 2016
Recombinant pharmaceuticals from microbial cells: a 2015 updateLaura Sanchez-Garcia, Lucas Martín, Ramon Mangues, et al.
Oncotarget|April 27, 2017
Stroma-derived HGF drives metabolic adaptation of colorectal cancer to angiogenesis inhibitorsAlessia Mira, Virginia Morello, Maria Virtudes Céspedes, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 19, 2002
Codon 12 and codon 13 mutations at the K-ras gene induce different soft tissue sarcoma types in nude miceSílvia Guerrero, Agnès Figueras, Isolda Casanova, et al.
Current Opinion in Pharmacology|January 28, 2019
Protein-driven nanomedicines in oncotherapyIsolda Casanova, Ugutz Unzueta, Irene Arroyo-Solera, et al.
Cancer Research|August 5, 2008
Bobel-24 and derivatives induce caspase-independent death in pancreatic cancer regardless of apoptotic resistanceMatilde Parreño, Isolda Casanova, María Virtudes Céspedes, et al.
Chemistryopen|April 13, 2019
Efficient bioactive oligonucleotide-protein conjugation for cell-targeted cancer therapyAnna Aviñó, Ugutz Unzueta, María Virtudes Céspedes, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Nanomedicine (London, England)|May 26, 2016
Functional recruitment for drug delivery through protein-based nanotechnologiesEsther Vazquez, Ramon Mangues, Antonio Villaverde
Medical Sciences (Basel, Switzerland)|October 31, 2017
Targeting in Cancer TherapiesRamon Mangues, Esther Vázquez, Antonio Villaverde
Biomarker Research|April 30, 2025
Targeting the chemokine receptor CXCR4 for cancer therapiesAriana Rueda, Naroa Serna, Ramon Mangues, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 28, 2002
Heterotopic implantation alters the regulation of apoptosis and the cell cycle and generates a new metastatic site in a human pancreatic tumor xenograft modelLourdes Farré, Isolda Casanova, Silvia Guerrero, et al.
Microbial Cell Factories|February 11, 2016
Recombinant pharmaceuticals from microbial cells: a 2015 updateLaura Sanchez-Garcia, Lucas Martín, Ramon Mangues, et al.
Oncotarget|April 27, 2017
Stroma-derived HGF drives metabolic adaptation of colorectal cancer to angiogenesis inhibitorsAlessia Mira, Virginia Morello, Maria Virtudes Céspedes, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 19, 2002
Codon 12 and codon 13 mutations at the K-ras gene induce different soft tissue sarcoma types in nude miceSílvia Guerrero, Agnès Figueras, Isolda Casanova, et al.
Current Opinion in Pharmacology|January 28, 2019
Protein-driven nanomedicines in oncotherapyIsolda Casanova, Ugutz Unzueta, Irene Arroyo-Solera, et al.
Cancer Research|August 5, 2008
Bobel-24 and derivatives induce caspase-independent death in pancreatic cancer regardless of apoptotic resistanceMatilde Parreño, Isolda Casanova, María Virtudes Céspedes, et al.
Chemistryopen|April 13, 2019
Efficient bioactive oligonucleotide-protein conjugation for cell-targeted cancer therapyAnna Aviñó, Ugutz Unzueta, María Virtudes Céspedes, et al.
Pageof 6